World

U.S. military sinks alleged drug boat in eastern Pacific

Mar 21, 2026

Washington DC [US], March 21: The U.S. military sank an alleged drug-trafficking boat in the eastern Pacific on Thursday and three people aboard survived the strike, the U.S. Southern Command said Friday.
"Intelligence confirmed the low-profile vessel was transiting along known narco-trafficking routes in the Eastern Pacific and was engaged in narco-trafficking operations," the command said in a press release, accusing the boat of being "operated by Designated Terrorist Organizations."
"Following the engagement, USSOUTHCOM immediately notified U.S. Coast Guard to activate the Search and Rescue system for the survivors. No U.S. military forces were harmed," said the statement.
Since September 2025, the U.S. military has conducted 46 known airstrikes on suspected drug-trafficking boats and killed at least 157 people aboard.
Commander of U.S. Southern Command Francis Donovan told the Senate Armed Services Committee at a hearing on Thursday that the airstrikes on alleged drug-trafficking boats "aren't the answer" to U.S. drug problems.
"Looking forward, senator -- the boat strikes aren't the answer," Donovan said at the hearing. "I believe that actually kinetic strikes will be one of the many tools, and probably not the most effective tool, when we actually look at it as more of a campaign approach."
Earlier this month, the Inter-American Commission on Human Rights held a hearing in Guatemala City on the legality of U.S. boat strikes in the Caribbean and their impact on communities across Latin America, according to a news release from the American Civil Liberties Union.
Source: Xinhua News Agency

More news

STL delivers resilient FY'26 performance; AI Data Centre business emerges as key growth engine

Mumbai (Maharashtra) [India], April 29: STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure, today announced its financial results for the year ended 31 March, 2026. The Company reported revenues of INR 1,441 Cr for the quarter and INR 4,745 Cr for FY26, a growth of ~14.7% QoQ and 18.8% YoY. In FY26, STL delivered EBITDA margins at ~13.2% and EBITDA of INR 628 Cr. The year was characterised by a transformative ~110% surge in order intake over FY25. This indicates strong revenue visibility and sets the stage for sustained growth in the coming quarters.

Apr 29, 2026